MedTrace Logo

Nutritional Supplementation in Sarcopenic Obesity

NCT05143398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-12-03

No results posted yet for this study

Summary

The obese patient presents a quantitative and qualitative deficit of muscle mass as occurs in the elderly subject that was named Sarcopenic Obesity (SO). The use of a diet that includes protein supplements and / or essential amino acids seems to improve this condition in the elderly; there are no similar studies in obese subjects, in particular during a low-calorie diet and physical activity program that can produce further loss of muscle mass. This study aims to verify whether the administration of these supplements (protein or amino acid) in the obese patient are effective in improving anthropometric and functional parameters and some serum markers of muscle metabolism. The results obtained could represent new therapeutic protocols in the treatment of obesity.

Conditions

  • Sarcopenic Obesity

Interventions

DIETARY_SUPPLEMENT

Diet + protein

Comparison of the efficacy

DIETARY_SUPPLEMENT

Diet + EAA

Comparison of the efficacy

DIETARY_SUPPLEMENT

Diet + EAA and TCA

Comparison of the efficacy

OTHER

Diet

Comparison of the efficacy

Sponsors & Collaborators

  • Istituto Auxologico Italiano

    lead OTHER

Principal Investigators

  • Amelia Brunani, MD · Istituto Auxologico Italiano

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2020-10-15
Completion
2021-03-10

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05143398 on ClinicalTrials.gov